EHA Unplugged

Prof Jorge Sierra provides an overview of myeloma, delving into its clinical aspects and sharing his personal passion for the disease. Together with host Prof. Konstanze Döhner, they explore myeloma's treatment challenges and advancements. Prof. Sierra also offers valuable advice on initiating myeloma research, making this an engaging podcast for students, trainees, and young hematologists alike. ...

In this episode, we talk to Dr. Umut Yilmaz from İstanbul University-Cerrahpaşa. Umut shares his interest in lymphoma, its diversity, and the challenges in his work. He also offers unique advice for inspiring starting hematologists and calls for more people to join the exciting field of lymphoma research and treatment.    Guest: Dr Umut Yilmaz  İstanbul University-Cerrahpaşa, Istanbul, Turkey   Ho...

Our guests Dr Anastasia Conti, Assoc Prof Maria Paola Martelli and Dr Simona Valletta give an overview on starting research in hematology. They go through their experience, give advice and talk about the challenges they face. The podcast starts with the basics of how to get started in hematology research, starting how to come up with research ideas and how to develop these ideas into projects. Our...

Listen as guest Dr Mirjam Belderbos talk to our host Prof Kirsten Grønbæk about her own experience in pediatric hematology, how she interacts with her patients and their family, the challenges in the field and how it differs from adult hematology. She also indulge us in the fun annual custom her pediatric unit does and how rewarding her role is to her. She ends by giving some advice to trainees an...

This week, we have guest Prof Laura Silvestri from Vita-Salute San Raffaele University who gives an amazing overview of iron regulation from the perspective of the protein hepcidin. Prof Silvestri illustrates the mechanism behind hepcidin regulation and how is transcription effected by proinflammatory cytokines in certain hematological disorders. Host: Dr Enrica Orsini; Guest: Prof Laura Silvestri...

In this episode, Prof David Rees gives an overview of acute chest syndrome (ACS) in SCD. Prof Rees and host Dr Enrica Orsini talk about epidemiology, the clinical picture, patient management, and the importance of recognizing this disease.  Host: Dr Enrica Orsini; Guest: Prof David Rees What did you think of this podcast? Share your opinions with us in this short feedback survey. Provide Feedback...

In this episode, Prof Maria Teressa Voso talks about MDS classification and risk assessment. She explains the different risk scores, the importance of molecular genetics in classification, risk stratification and management in MDS patients. Guest: Prof Maria Teressa Voso ; Host: Dr Enrica Orsini What did you think of this podcast? Share your opinions with us in this short feedback survey. Provide...

Listen as our guest Prof. Martina Muckenthaler and host Dr. Isabel Olivera Martinez give an overview on anemia of inflammation. They discuss the pathogenesis of the disease and the current treatment landscape in particular with HIF-PH inhibitors, and hepcidin as a target in certain disease entities. What did you think of this podcast?  Share your opinions  with us in a short feedback survey. Guest...

Listen as  Dr. Maria Themeli  and  Dr. Ciprian Tomuleasa  provide an overview of the latest developments and novel ideas in CAR-T therapy. This podcast episode is part of our  FREE course on CAR-T Updates  on the  EHA Campus . Prominent experts provide an overview of CAR-T treatment in different diseases, discussing clinical management, economic and regulatory aspects, and future developments.   ...

Listen as Dr. Anna Sureda explains the available CAR-T treatments for lymphomas, focusing on DLBCL (diffuse large B cell lymphoma) and the challenges of CAR-T therapy in the current treatment landscape. She also considers the possibility of using CAR-T cells in 2nd line treatment (or earlier) and in combination with other drugs.   This podcast episode is part of our  FREE course on CAR-T Updates  ...

In this episode Dr Wilson Lim interviews our guest Prof. Carlos Fernández de Larrea  on CAR-T toxicities and how to control or avoid adverse reactions to CAR-T therapies in patients with myeloma. Guest: Prof. Carlos Fernández de Larrea ; Host: Dr Wilson Lim This podcast episode is part of our  FREE course on CAR-T Updates  on the  EHA Campus . Prominent experts provide an overview of CAR-T treatme...

Listen as Dr. Anna Sureda discusses CAR-T therapy from a patients perspective and the steps that physicians can take to help patients overcome the challenges that comes with CAR-T treatment.   This podcast episode is part of our  FREE course on CAR-T Updates  on the  EHA Campus . Prominent experts provide an overview of CAR-T treatment in different diseases, discussing clinical management, economi...

Listen as Emeritus Prof Robin Foà brings you on the journey of Ph+ ALL management together with our host Dr Enrica Orsini. With a long career in ALL, Prof Foà runs through the history of Ph+ ALL, his experience in patient management, and then brings you up to date on the current picture in patient management. Tune in as Prof Foà describes the breakthrough in treatment with TKI inhibitors and the i...

Join us for another episode of EHA Unplugged. We have Prof. Herman Einsele here talking about the current landscapes of CAR-T therapy in myeloma, results achievable today, and the future perspectives for these patients. This podcast episode is part of our  FREE course on CAR-T Updates  on the  EHA Campus . Prominent experts provide an overview of CAR-T treatment in different diseases, discussing c...

Join us here at EHA Unplugged with another episode on CAR-T updates. Listen as our guest Prof. Chiara Bonini  and host Dr. Wilson Lim discuss the reasons for CAR-T therapy failure and relapse after treatment. This podcast episode is part of our  FREE course on CAR-T Updates  on the  EHA Campus . Prominent experts provide an overview of CAR-T treatment in different diseases, discussing clinical man...

Listen as  Prof. Christian Chabannon  provides an overview of the challenges and obstacles raised by the economic aspects of CAR-T treatment. He examines different solutions and proposes a way forward to address these issues.   This podcast episode is part of our  FREE course on CAR-T Updates  on the  EHA Campus . Prominent experts provide an overview of CAR-T treatment in different diseases, disc...

Listen as  Prof. John Gribben  provides an update on where we are with CAR-T in acute and chronic leukemias.  This podcast episode is part of our  FREE course on CAR-T Updates  on the  EHA Campus . Prominent experts provide an overview of CAR-T treatment in different diseases, discussing clinical management, economic and regulatory aspects, and future developments.  What did you think of this podc...

Prof Günter Weiss, from the University of Innsbruck, Germany, provides in this podcast a comprehensive pathogenetic and clinical overview of a relevant and frequent medical problem: Absolute Iron Deficiency, defined as the combination of anemia of chronic disease (ACD) and iron deficiency anemia (IDA) in people suffering from inflammatory disorders. The complex functional mechanisms and underlying...

Listen as Prof. Carl June provides an overview of the past and current landscape and challenges in CAR-T therapy, along with a summary of the innovations being introduced to lower the cost of CAR-T and improve CAR-T treatment and access. This podcast episode is part of our FREE course on CAR-T Updates on the EHA Campus . Prominent experts provide an overview of CAR-T treatment in different disease...

In this podcast, Hartmut Döhner, Hematologist-Oncologist and Professor of Medicine in Germany, discusses with Dr. Nathalie van Havre the role of genomic characterization in the classification, prognosis and treatment of myeloid neoplasms. Discover the main methods of genomic testing, the kind of relevant information they can provide, and the essential techniques that should currently be available...

In this podcast about gene therapy for hemoglobinopathies, our experts Dr. Evangelia Yanaki and Professor Franco Locatelli discuss the most effective approach for treating patients with these conditions, considering the safety concerns and potential complications associated, as well as the need for long-term monitoring of patients.  In this debate recorded during the EHA22 Annual Congress, Dr. Yan...

In this episode, guest Prof Martin Dreyling and host Dr Nathalie van Havre discuss the latest developments in lymphoid malignancies and the research roadmap that has been put in place to guide future research. Professor Dreyling highlights the move away from traditional chemotherapy towards non-cytostatic approaches and discusses the long-term complications of traditional treatments and the need f...

In this episode of EHA Unplugged, Prof Beverly Hunt discusses the global consequences of postpartum hemorrhage (PPH) and the unacceptable PPH-related mortality rate in developed countries. The discussion continues on the challenges faced in the identification of PPH and the primary causes of PPH. Prof Hunt further talks about the consequences of PPH on children and emphasizes the need for more res...

Join Prof Paolo Ghia and our host Dr Enrica Orsini as they discuss the treatment of Chronic Lymphocytic Leukemia (CLL) from the perspectives of patients and doctors. In this episode, they discuss the factors that influence the decision of treatment choices from the perspectives of patients and doctors and how both parties have different perspectives on the subject. They further highlight the impor...

In this podcast, hear from Prof Hartmut Döhner, Hematologist-Oncologist and Professor of Medicine in Germany, as he discusses the growing roles of precise treatments based on the characteristics of the leukemic cells in acute myeloid leukemias. Discover the clinical developments of targeted treatments such as IDH1/2 inhibitors and venetoclax, and learn about the importance of combination treatment...